Showing results (1-10 of 378) with videos related to
Sort By:
Pageof 38
Vitamins and Hormones|February 11, 2000
HIV protease: enzyme function and drug resistanceS Gulnik, J W Erickson, D XieProtein Science : a Publication of the Protein Society|December 14, 1999
Real-time measurements of dark substrate catalysisD Xie, L Suvorov, J W Erickson, et al.Biochemistry|January 24, 1998
Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residuesD Xie, S Gulnik, L Collins, et al.Protein Science : a Publication of the Protein Society|August 19, 1999
Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pHD Xie, S Gulnik, E Gustchina, et al.FEBS Letters|May 20, 2000
A novel putative transcription factor protein MYT2 that preferentially binds supercoiled DNA and induces DNA synthesis in quiescent cellsW Shao, A Y Lee, S Gulnik, et al.Structure (London, England : 1993)|June 15, 1995
Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatineE T Baldwin, T N Bhat, S Gulnik, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug designE T Baldwin, T N Bhat, S Gulnik, et al.Journal of Molecular Biology|September 5, 1992
Human liver cathepsin D. Purification, crystallization and preliminary X-ray diffraction analysis of a lysosomal enzymeS Gulnik, E T Baldwin, N Tarasova, et al.Biochemistry|June 24, 1998
Thermodynamics of a transition state analogue inhibitor binding to Escherichia coli chorismate mutase: probing the charge state of an active site residue and its role in inhibitor binding and catalysisA Y Lee, S Zhang, P Kongsaeree, et al.Pageof 38